MedPath

Women With Asymptomatic Endometrial Hyperplasia

Completed
Conditions
Endometrial Hyperplasia
Registration Number
NCT02100137
Lead Sponsor
Medical University of Vienna
Brief Summary

The purpose of this study is to evaluate the clinical meaning of an endometrial hyperplasia diagnosed using a vaginal ultrasound during routine gynecological examination.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1000
Inclusion Criteria
  • asymptomatic women with endometrial hyperplasia diagnosed using a vaginal ultrasound
Exclusion Criteria
  • postmenopausal bleeding

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of invasive endometrial cancersParticipants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days
Secondary Outcome Measures
NameTimeMethod
Number of women with atypical endometrial hyperplasiaParticipants will be followed for the duration of hospital and until the results of the final histology from the endometrial biopsy are completed, for an expected average of 10 days

Trial Locations

Locations (1)

Medical University of Vienna

🇦🇹

Vienna, Austria

Medical University of Vienna
🇦🇹Vienna, Austria

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.